

|
In a recent industry letter, the FDA’s Center for Devices and Radiological Health urged medical device firms to use discernment when selecting third-party labs for performance testing. The letter described an uptick in premarket submissions with unreliable and fraudulent test data from third-party labs, particularly overseas providers. Unqualified third-party labs may provide firms with performance…